PYXS

1.8107.74%
JW

Jitendra Wadhane

Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer

Mr. Jitendra Wadhane, also known as Jitu, C.A, C.P.A., is Principal Financial Officer of Pyxis Oncology, Inc. from July 1, 2025 and has been Chief Accounting Officer since August 3, 2022 and has been its Senior Vice President of Finance and Corporate Controller since August 2021. From April 2020 to August 2021, Mr. Wadhane was Head of SEC Reporting and Technical Accounting at Immunovant, Inc., a biopharmaceutical company and from February 2012 to April 2020, he was a Senior Manager with Ernst & Young LLP, an accounting firm. Mr. Wadhane is a Certified Public Accountant and received his Bachelors Degree from the University of Mumbai and Chartered Accountancy from the Institute of Chartered Accountants of India.

Positions